nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenbufen—PTGS2—urinary bladder cancer	0.65	1	CbGaD
Fenbufen—PTGS2—Cisplatin—urinary bladder cancer	0.108	0.356	CbGbCtD
Fenbufen—PTGS2—Etoposide—urinary bladder cancer	0.106	0.349	CbGbCtD
Fenbufen—PTGS1—Etoposide—urinary bladder cancer	0.0899	0.295	CbGbCtD
Fenbufen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.0017	0.0505	CbGpPWpGaD
Fenbufen—Suprofen—UGT2B7—urinary bladder cancer	0.00169	0.177	CrCbGaD
Fenbufen—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—urinary bladder cancer	0.00158	0.0467	CbGpPWpGaD
Fenbufen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—urinary bladder cancer	0.00135	0.0401	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00116	0.0343	CbGpPWpGaD
Fenbufen—Tolmetin—CXCL8—urinary bladder cancer	0.000999	0.104	CrCbGaD
Fenbufen—Balsalazide—PPARG—urinary bladder cancer	0.000954	0.0998	CrCbGaD
Fenbufen—Flurbiprofen—UGT2B7—urinary bladder cancer	0.000953	0.0996	CrCbGaD
Fenbufen—PTGS2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000919	0.0272	CbGpPWpGaD
Fenbufen—PTGS1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000811	0.024	CbGpPWpGaD
Fenbufen—Tolmetin—MPO—urinary bladder cancer	0.000777	0.0813	CrCbGaD
Fenbufen—PTGS2—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.000737	0.0218	CbGpPWpGaD
Fenbufen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000716	0.0212	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000616	0.0183	CbGpPWpGaD
Fenbufen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—urinary bladder cancer	0.000594	0.0176	CbGpPWpGaD
Fenbufen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	0.000557	0.0165	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—GSTZ1—urinary bladder cancer	0.000552	0.0164	CbGpPWpGaD
Fenbufen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	0.000543	0.0161	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—GSTO2—urinary bladder cancer	0.000523	0.0155	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—NAT1—urinary bladder cancer	0.000523	0.0155	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000522	0.0155	CbGpPWpGaD
Fenbufen—PTGS2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000489	0.0145	CbGpPWpGaD
Fenbufen—Ketoprofen—CXCL8—urinary bladder cancer	0.000487	0.0509	CrCbGaD
Fenbufen—PTGS1—Biological oxidations—UGT2B7—urinary bladder cancer	0.000478	0.0142	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—PTGS2—urinary bladder cancer	0.000465	0.0138	CbGpPWpGaD
Fenbufen—Ketorolac—PTGS2—urinary bladder cancer	0.000452	0.0473	CrCbGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000451	0.0134	CbGpPWpGaD
Fenbufen—Bromfenac—PTGS2—urinary bladder cancer	0.000433	0.0453	CrCbGaD
Fenbufen—PTGS1—Biological oxidations—CYP4B1—urinary bladder cancer	0.000431	0.0128	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000421	0.0125	CbGpPWpGaD
Fenbufen—PTGS2—S1P1 pathway—RHOA—urinary bladder cancer	0.000408	0.0121	CbGpPWpGaD
Fenbufen—Balsalazide—PTGS2—urinary bladder cancer	0.000403	0.0421	CrCbGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000387	0.0115	CbGpPWpGaD
Fenbufen—PTGS1—Eicosanoid Synthesis—PTGS2—urinary bladder cancer	0.000386	0.0114	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000373	0.011	CbGpPWpGaD
Fenbufen—Tiaprofenic acid—PTGS2—urinary bladder cancer	0.000369	0.0385	CrCbGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000364	0.0108	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—CXCL8—urinary bladder cancer	0.000358	0.0106	CbGpPWpGaD
Fenbufen—Nepafenac—PTGS2—urinary bladder cancer	0.000351	0.0367	CrCbGaD
Fenbufen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—urinary bladder cancer	0.000323	0.00957	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000319	0.00945	CbGpPWpGaD
Fenbufen—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—urinary bladder cancer	0.000315	0.00935	CbGpPWpGaD
Fenbufen—PTGS1—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000314	0.00931	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000307	0.0091	CbGpPWpGaD
Fenbufen—Oxaprozin—PTGS2—urinary bladder cancer	0.000291	0.0305	CrCbGaD
Fenbufen—Salsalate—PTGS2—urinary bladder cancer	0.000291	0.0305	CrCbGaD
Fenbufen—Tolmetin—PTGS2—urinary bladder cancer	0.000291	0.0305	CrCbGaD
Fenbufen—PTGS2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000289	0.00857	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—NAT2—urinary bladder cancer	0.000287	0.0085	CbGpPWpGaD
Fenbufen—Suprofen—PTGS2—urinary bladder cancer	0.000279	0.0292	CrCbGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000254	0.00752	CbGpPWpGaD
Fenbufen—PTGS2—Overview of nanoparticle effects—TNF—urinary bladder cancer	0.000249	0.00739	CbGpPWpGaD
Fenbufen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—urinary bladder cancer	0.000244	0.00723	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000243	0.0072	CbGpPWpGaD
Fenbufen—Fenoprofen—PTGS2—urinary bladder cancer	0.000241	0.0252	CrCbGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—urinary bladder cancer	0.000238	0.00706	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000232	0.00687	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.000229	0.00679	CbGpPWpGaD
Fenbufen—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000222	0.00659	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000221	0.00656	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000219	0.0065	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—urinary bladder cancer	0.000216	0.00641	CbGpPWpGaD
Fenbufen—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000214	0.00636	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000214	0.00634	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000199	0.00591	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000199	0.00591	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000193	0.00572	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000184	0.00545	CbGpPWpGaD
Fenbufen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	0.000171	0.00508	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.00017	0.00503	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000167	0.00496	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000166	0.00493	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000165	0.0049	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—urinary bladder cancer	0.000165	0.00489	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000159	0.00472	CbGpPWpGaD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—urinary bladder cancer	0.000158	0.00468	CbGpPWpGaD
Fenbufen—Flurbiprofen—PTGS2—urinary bladder cancer	0.000157	0.0164	CrCbGaD
Fenbufen—PTGS1—prostate gland—urinary bladder cancer	0.000157	0.0904	CbGeAlD
Fenbufen—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000154	0.00457	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000151	0.00449	CbGpPWpGaD
Fenbufen—PTGS2—prostate gland—urinary bladder cancer	0.00015	0.0864	CbGeAlD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000147	0.00436	CbGpPWpGaD
Fenbufen—Ketoprofen—PTGS2—urinary bladder cancer	0.000142	0.0149	CrCbGaD
Fenbufen—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000142	0.0042	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000137	0.00407	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000136	0.00404	CbGpPWpGaD
Fenbufen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000135	0.004	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000134	0.00397	CbGpPWpGaD
Fenbufen—PTGS1—seminal vesicle—urinary bladder cancer	0.000133	0.0765	CbGeAlD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000132	0.00391	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000131	0.00389	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000129	0.00382	CbGpPWpGaD
Fenbufen—PTGS2—seminal vesicle—urinary bladder cancer	0.000127	0.0731	CbGeAlD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000123	0.00364	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000122	0.00361	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.00012	0.00356	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	0.00012	0.00355	CbGpPWpGaD
Fenbufen—PTGS1—epithelium—urinary bladder cancer	0.000115	0.0664	CbGeAlD
Fenbufen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	0.000115	0.00341	CbGpPWpGaD
Fenbufen—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000111	0.064	CbGeAlD
Fenbufen—PTGS2—epithelium—urinary bladder cancer	0.00011	0.0635	CbGeAlD
Fenbufen—PTGS1—renal system—urinary bladder cancer	0.000107	0.0616	CbGeAlD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000106	0.00316	CbGpPWpGaD
Fenbufen—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000106	0.0612	CbGeAlD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000105	0.0031	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	0.000104	0.00309	CbGpPWpGaD
Fenbufen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000104	0.00307	CbGpPWpGaD
Fenbufen—PTGS2—renal system—urinary bladder cancer	0.000102	0.0589	CbGeAlD
Fenbufen—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.000102	0.00301	CbGpPWpGaD
Fenbufen—PTGS2—urethra—urinary bladder cancer	0.0001	0.0578	CbGeAlD
Fenbufen—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	9.82e-05	0.00291	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	9.46e-05	0.0028	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	9.44e-05	0.0028	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	9.35e-05	0.00277	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.26e-05	0.00275	CbGpPWpGaD
Fenbufen—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.21e-05	0.00273	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTO2—urinary bladder cancer	8.95e-05	0.00265	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—NAT1—urinary bladder cancer	8.95e-05	0.00265	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.8e-05	0.00261	CbGpPWpGaD
Fenbufen—PTGS1—female reproductive system—urinary bladder cancer	8.57e-05	0.0493	CbGeAlD
Fenbufen—PTGS2—Disease—GSTO2—urinary bladder cancer	8.48e-05	0.00251	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	8.31e-05	0.00246	CbGpPWpGaD
Fenbufen—PTGS2—female reproductive system—urinary bladder cancer	8.19e-05	0.0472	CbGeAlD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.19e-05	0.00243	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	8.18e-05	0.00243	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.15e-05	0.00242	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	8.15e-05	0.00241	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.12e-05	0.00241	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	7.94e-05	0.00235	CbGpPWpGaD
Fenbufen—PTGS1—vagina—urinary bladder cancer	7.75e-05	0.0446	CbGeAlD
Fenbufen—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	7.74e-05	0.00229	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	7.53e-05	0.00223	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	7.51e-05	0.00223	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	7.49e-05	0.00222	CbGpPWpGaD
Fenbufen—PTGS2—vagina—urinary bladder cancer	7.41e-05	0.0427	CbGeAlD
Fenbufen—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	7.37e-05	0.00218	CbGpPWpGaD
Fenbufen—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.31e-05	0.00217	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.11e-05	0.00211	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTO2—urinary bladder cancer	7.1e-05	0.00211	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—NAT1—urinary bladder cancer	7.1e-05	0.00211	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.03e-05	0.00208	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.98e-05	0.00207	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	6.96e-05	0.00206	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PRSS3—urinary bladder cancer	6.78e-05	0.00201	CbGpPWpGaD
Fenbufen—PTGS2—Disease—SLC19A1—urinary bladder cancer	6.59e-05	0.00195	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	6.49e-05	0.00193	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PRSS3—urinary bladder cancer	6.43e-05	0.00191	CbGpPWpGaD
Fenbufen—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	6.4e-05	0.0019	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	6.21e-05	0.00184	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HDAC4—urinary bladder cancer	6.13e-05	0.00182	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	6.07e-05	0.0018	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.96e-05	0.00177	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	5.85e-05	0.00173	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	5.78e-05	0.00171	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	5.52e-05	0.00164	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.44e-05	0.00161	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—TYMP—urinary bladder cancer	5.42e-05	0.00161	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PRSS3—urinary bladder cancer	5.38e-05	0.0016	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.26e-05	0.00156	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.21e-05	0.00154	CbGpPWpGaD
Fenbufen—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	5.1e-05	0.00151	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.09e-05	0.00151	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.08e-05	0.00151	CbGpPWpGaD
Fenbufen—PTGS1—lymph node—urinary bladder cancer	5.01e-05	0.0289	CbGeAlD
Fenbufen—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.9e-05	0.00145	CbGpPWpGaD
Fenbufen—PTGS2—Disease—LIG1—urinary bladder cancer	4.87e-05	0.00144	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.85e-05	0.00144	CbGpPWpGaD
Fenbufen—PTGS2—lymph node—urinary bladder cancer	4.79e-05	0.0276	CbGeAlD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.71e-05	0.0014	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.32e-05	0.00128	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—TYMP—urinary bladder cancer	4.3e-05	0.00128	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—RRM2—urinary bladder cancer	4.23e-05	0.00125	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.22e-05	0.00125	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.13e-05	0.00123	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.13e-05	0.00122	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.93e-05	0.00117	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.92e-05	0.00116	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.92e-05	0.00116	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.9e-05	0.00116	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.9e-05	0.00115	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.89e-05	0.00115	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.8e-05	0.00113	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.74e-05	0.00111	CbGpPWpGaD
Fenbufen—PTGS2—Disease—ENO2—urinary bladder cancer	3.71e-05	0.0011	CbGpPWpGaD
Fenbufen—PTGS2—Disease—RBX1—urinary bladder cancer	3.52e-05	0.00104	CbGpPWpGaD
Fenbufen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.47e-05	0.00103	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—RRM2—urinary bladder cancer	3.36e-05	0.000996	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—NQO1—urinary bladder cancer	3.16e-05	0.000936	CbGpPWpGaD
Fenbufen—PTGS2—Disease—JAG1—urinary bladder cancer	3.15e-05	0.000934	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—HPGDS—urinary bladder cancer	3.11e-05	0.000922	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—ENO2—urinary bladder cancer	3.11e-05	0.000922	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.09e-05	0.000917	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.06e-05	0.000908	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTT1—urinary bladder cancer	3.02e-05	0.000894	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.97e-05	0.000881	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.67e-05	0.000792	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.63e-05	0.000781	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.55e-05	0.000756	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—NQO1—urinary bladder cancer	2.51e-05	0.000743	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.45e-05	0.000726	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2.42e-05	0.000718	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2.42e-05	0.000718	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—GPX1—urinary bladder cancer	2.32e-05	0.000687	CbGpPWpGaD
Fenbufen—PTGS2—Disease—NCOR1—urinary bladder cancer	2.29e-05	0.00068	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—ERCC2—urinary bladder cancer	2.28e-05	0.000675	CbGpPWpGaD
Fenbufen—PTGS2—Disease—ERCC2—urinary bladder cancer	2.16e-05	0.00064	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	0.000634	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.12e-05	0.000629	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTP1—urinary bladder cancer	2.09e-05	0.00062	CbGpPWpGaD
Fenbufen—PTGS2—Disease—MTHFR—urinary bladder cancer	2.03e-05	0.000601	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.02e-05	0.0006	CbGpPWpGaD
Fenbufen—PTGS2—Disease—TERT—urinary bladder cancer	2.02e-05	0.0006	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.94e-05	0.000576	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.92e-05	0.00057	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.92e-05	0.00057	CbGpPWpGaD
Fenbufen—PTGS2—Disease—FGFR3—urinary bladder cancer	1.86e-05	0.00055	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000546	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.81e-05	0.000536	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.73e-05	0.000514	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.7e-05	0.000504	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	0.000494	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CREBBP—urinary bladder cancer	1.58e-05	0.000468	CbGpPWpGaD
Fenbufen—PTGS2—Disease—RHOA—urinary bladder cancer	1.43e-05	0.000424	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000408	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.36e-05	0.000405	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.000392	CbGpPWpGaD
Fenbufen—PTGS2—Disease—ERBB2—urinary bladder cancer	1.32e-05	0.000392	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000353	CbGpPWpGaD
Fenbufen—PTGS1—Metabolism—EP300—urinary bladder cancer	1.14e-05	0.000336	CbGpPWpGaD
Fenbufen—PTGS2—Disease—CDKN1A—urinary bladder cancer	1.13e-05	0.000335	CbGpPWpGaD
Fenbufen—PTGS2—Disease—PTEN—urinary bladder cancer	1.13e-05	0.000334	CbGpPWpGaD
Fenbufen—PTGS2—Disease—EP300—urinary bladder cancer	1.08e-05	0.000319	CbGpPWpGaD
Fenbufen—PTGS2—Disease—SRC—urinary bladder cancer	1.05e-05	0.00031	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—PTEN—urinary bladder cancer	9.45e-06	0.00028	CbGpPWpGaD
Fenbufen—PTGS2—Disease—MYC—urinary bladder cancer	9.38e-06	0.000278	CbGpPWpGaD
Fenbufen—PTGS2—Disease—EGFR—urinary bladder cancer	9.17e-06	0.000272	CbGpPWpGaD
Fenbufen—PTGS2—Metabolism—EP300—urinary bladder cancer	9.01e-06	0.000267	CbGpPWpGaD
Fenbufen—PTGS2—Disease—KRAS—urinary bladder cancer	8.66e-06	0.000257	CbGpPWpGaD
Fenbufen—PTGS2—Disease—HRAS—urinary bladder cancer	7.36e-06	0.000218	CbGpPWpGaD
